Theravance SUBMITS Regulatory App and 2 Stocks Enjoying 52-Week Highs

Theravance (NASDAQ:THRX) and GlaxoSmithKline plc (NYSE:GSK) have reported the submission of regulatory applications in the U.S. and in the European Union for the once-daily investigational medicine fluticasone furoate “FF”/vilanterol “VI”, for patients suffering from chronic obstructive pulmonary disease, or COPD, and also a regulatory application for asthma in the European Union. Shares closed up 0.55 percent on the day at $29.49, having been traded between $12.91 and $29.87 the past 52 weeks.

The Justice Department is delaying Verizon Wireless’ (NYSE:VZ) reseller arrangements with cable providers on broadband pricing, due to worries concerning the impact. The Federal Communications Commission is ready to okay the deals, but Justice antitrust officials are concerned that the reseller arrangements amount to non competition agreements which will restrict consumer broadband options, especially in areas where Verizon’s FiOS service isn’t offered. Shares closed up 1.21 percent on the day at $45.21, and have been traded between $32.28 and $45.07 the past 52 weeks.

Wal-Mart Stores Inc. (NYSE:WMT) is among a group of discounters, including Target (NYSE:TGT), that is using food to draw shoppers into their stores, says the Wall Street Journal. Traditional supermarkets’ portion of domestic grocery sales have plummeted from 66 percent in 2000, to 51 percent in 2011, according to UBS. Some analysts think that the discounter tactics above are a part of the cause. Shares closed up 1.2 percent on the day at $73.18, having traded in a 52-week range of $48.31 to $72.62.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.